Uma wena noma othandekayo ene- MS eqhubekayo , ungase uzizwe ukhathazekile noma uphazamisekile ukuthi ayikho imithi evunyiwe yesifo sakho. Kodwa qiniseka ukuthi, abacwaningi basebenza kanzima, futhi ukwelapha kuyaphuma.
Enye yezokwelapha okunjalo ukubunjwa kwezinga eliphezulu le-vitamin biotin. Ake sihlolisise ucwaningo lwesayensi ngemuva kwe-biotin ekwelapheni i-multiple sclerosis.
I-MS eqhubekela phambili ne-MS-Reving-MS
Ngenkathi iningi labantu abane-multiple sclerosis selibuyisela kabusha i-MS (cishe ngamaphesenti angu-85), i-subset encane (cishe amaphesenti angu-10 kuya kwangu-15) ine- MS eyinhloko eqhubekayo. Lokhu kusho ukuthi abakutholi ukubuyiselwa kobuciko bokungasebenzi kahle kwegazi.
I-biology ngemuva kokuphindaphindiwe kwe-MS ukuthi uhlelo lomzimba lomuntu luhlasela umkhuhlane we-myelin. Ngamanye amazwi, ukuphindaphinda kuyinkqubo eqhutshwa ukuvuvukala. Kodwa ku-MS okuqhubekayo, inqubo encane yokuvuvukala nokunye okunokukhubazeka kwenzeka, lapho izintambo ze-nerve zinciphisa kancane kancane. Ngakho umuntu onomuntu oqhubekayo we-MS ukhula kancane kancane ekubhekaneni nokukhubazeka kwengqondo ngaphandle kwezikhathi zokuxolelwa.
I-term yesibili eqhubekayo i-MS ichaza umuntu owake wahlangenwe nakho, kodwa manje ushintshile ekwenzeni kancane kancane okuqhubekayo kwe-MS. Iningi labantu abane-MS ekubuyiseleni kabusha ekugcineni lishintsha kwi-MS yesibili eqhubekayo.
Noma, lokhu kungase kushintshwe ngokusetshenziswa kwezifo zokuguqula izifo zakuqala.
I-Biotin njengendlela yokwelashwa okungenzeka
Njengoba izifo zamanje eziguqula izifo (ezihlose amasosha omzimba omuntu) aziphumeleli ekwelapheni i-MS eqhubekayo (ngaphandle uma umuntu esabhekana nokubuyela emuva), abacwaningi bebelokhu bezama ukuthola izindlela zokwelashwa ezingabhekisela iphethini eqhubekayo ye-multiple sclerosis.
Ngamanye amazwi, umuthi ohlose isimiso sezinzwa zomphakathi hhayi amasosha omzimba.
Kubacwaningi, i-vitamin biotin ibonakala sengathi iyindlela enengqondo, ngokucabangela ukuthi itholakele ukuphatha ngokuphumelelayo ezinye izinkinga ezinkulu zesisindo sezinzwa eziphezulu kakhulu. Ngokwesayensi, ngabe i-biotin yayizosiza kanjani i-MS yomuntu eqhubekayo? I-Biotin idlala indima ekwenzeni ama-acids amafutha emzimbeni, kanti umgogodla we-myelin uyisikhumba esinamafutha. Ngakho-ke, ososayensi bacacisa ngokuthi i-biotin ingenza kusebenze ukuhlanganiswa kwamafutha acids, okungaholela ekukhoneni kwe-myelin futhi futhi kuvikelwe ekulimaleni kwe-nerve fiber nokulahleka.
I-Research Behind Biotin
Ucwaningo lokuqala oluhlola ukuphathwa kwe-MS okuqhubekayo nge-biotin kwaba isifundo seFrance ku- Multiple Sclerosis and Related Disorders . Kulolu cwaningo, abantu abangu-23 abanezinyathelo eziphambili (abantu abangu-14) noma ama-MS okuqhubekayo (abantu abayisishiyagalolunye) banikezwa amazinga aphezulu we-biotin nsuku zonke (100mg kuya ku-600mg) ngokulinganiselwa kwezinyanga ezingu-9.
Imiphumela yocwaningo yembula lokhu okulandelayo:
- Abantu abane babenenkinga yokulahlekelwa yimbono evela ku-MS-related optic nerve disease ngaphambi kokucwaninga. Bonke babenokuthuthukiswa kwezinto ezibonakalayo ezibonakalayo nge-dose ephakeme ye-biotin (300mg / ngosuku).
- Umuntu oyedwa wayene-Hemianopia yangakwesobunxele engazange ehlonzwe ngaphambi kokucwaninga (okusho ukuthi uhlangothi lwesobunxele lweso ngalinye alubonanga kahle). Lo muntu ube nokuthuthukiswa kombono, nakuba i-lesion yokuxhumanisa ebuchosheni bayo i-MRI yahlala ingashintshi.
- Abantu abangu-18 babenomthelela wokugaya umgogodla ngaphambi kocwaningo-abantu abangu-11 abane-tetraparesis eyingozi (ukukhubazeka okungapheli noma okuphelele kwamalungu omzimba) nabantu abayisikhombisa abane-paraparesis (ukukhubazeka okuncane noma okuphelele kwamalungu amabili). Abantu abangu-16 kulaba bantu abangu-18 (amaphesenti angu-89) babe ngcono (okwenzeka ezinyangeni ezimbili kuya kweziyisishiyagalombili emva kokuqala ukwelashwa kwe-biotin).
Kulabo abaphuthumayo (okwabikwa umhloli ophuphuthelwe ukubukeza ama-videotapes wokuhlolwa komtholampilo womhlanganyeli), ukuthuthukiswa okubonakalayo kubonwe ngezinga eliphakeme le-biotin, ku-300mg / ngosuku.
Ezinye izimpawu ezihlobene ne-MS nezimpawu ezithuthukisiwe zihlanganisa:
- ukukhathala (abantu abayisihlanu)
- ukugwinya ubunzima (abantu abane)
- inkulumo ephuthumayo noma enhle (abantu abathathu)
- izimpawu zokuzwa (abantu ababili)
- ukuhamba okungabonakali-okuthiwa i-gait ataxia (abantu ababili)
Ekugcineni, ukukhubazeka, njengoba kulinganiswa nge- EDSS score , ithuthukiswe kubantu abane kwabangu-23 (amaphesenti angu-22).
Umphumela omubi kuphela obikiwe kulolu cwaningo kwakuyisifo sohudo esiphuthumayo kubantu ababili. Umuntu oyedwa wabulawa ngenxa yokuhluleka kwenhliziyo eminyakeni emithathu ngemuva kokuqala ukwelashwa kwe-biotin futhi unyaka owodwa ngemuva kokuqeda ukwelashwa, umuntu wafa ngepneumonia ngemuva kokuhlinzwa okwenziwa ngekoloni. Zombili izimo zokufa azikholelwa ukuthi zihlobene nokuphathwa nge-biotin.
Futhi, khumbula ukuthi abantu abane-MS abaqhubekayo bangakwazi ukuphindaphindiwe ngezikhathi ezithile. Esicwaningweni, abantu abane (amaphesenti ayishumi nesishiyagalolunye) bahlangene okungenani ukuphindaphinda kwe-MS eyodwa. Kodwa ngokusho kwabacwaningi, le nombolo yayifana nalokho okwakubonwe kulaba bantu ngaphambi kokwelashwa nge-biotin. Ngamanye amazwi, i-biotin ayizange ibonakale engalungile noma enhle ithonya ukuthi kwenzeke ukuthi i-MS ibuyele emuva.
Enye i-Biotin Study for Treatment Progressive MS
Kwesinye isifundo seFrance ku- Multiple Sclerosis , abantu abane-MS noma i-MS eqhubekela phambili bangenasimo sokuthola i-biotin eyi-100mg noma i-placebo (amaphilisi abukeka futhi anambitha ngokufanayo) kathathu nsuku zonke (ngakho-ke inani le-300mg biotin nsuku zonke, uma kungenjalo i-placebo ).
Abahlanganyeli bokufunda noma abaphenyi bokucwaninga babengazi ukuthi ngubani owathola ipilisi ye-biotin futhi owathola iphilisi ye-placebo. Lokhu kwenziwa unyaka owodwa (obizwa ngokuthi isigaba sokuqala). Ekugcineni, abantu abangu-91 bathola iphilisi ye-biotin nabantu abangu-42 bathola iphilisi ye-placebo.
Khona-ke ngomunye unyaka, bonke abahlanganyeli (kubandakanye abahlanganyeli be-placebo bokuqala) bathola i-100mg biotin izikhathi ezintathu nsuku zonke (okuthiwa isigaba sokwandisa). Bengazi ukuthi ngabe babamukele yini i-biotin ngonyaka wokuqala noma i-placebo.
Imiphumela yabonisa ukuthi ama-13 (amaphesenti angu-12,6) wabathintekayo abaphatha nge-biotin kusukela ekuqaleni behlehlise ukukhubazeka kwabo okuhlobene ne-MS, futhi abangu-10 kulaba abahlanganyeli abangu-13 babelokhu bethuthukiswa ekupheleni kocwaningo (izinyanga ezingu-24). Abantu ababili abathola i-biotin esigabeni sokuqala abazange babonise ngcono ezinyangeni ezingu-12 zokuqala kodwa benza ekupheleni kwezinyanga ezingu-24.
Ukuphulukiswa kokukhubazeka kwalinganiswa noma kuncipha kwi-EDSS score kanye / noma ukunciphisa isikhathi esathatha ukuhamba ngamamitha angu-25. Umqaphi lapha ukuthi akukho ukuthuthukiswa eqenjini le-placebo, okuphakamisa ukuthi i-biotin yaba nomthelela weqiniso. Futhi, okufana nesifundo sokuqala esishiwo, i-biotin yayibekezeleleke kahle, ngaphandle kwemiphumela emibi kakhulu.
Lokhu kusho konke, okuphathelene nokukhishwa okushiwo abalobi bokutadisha ukuthi labo abathola i-biotin babenezinkinga ezintsha noma ezikhulisa ubuchopho (njengoba kuboniswe kwi-MRI) kunabanye beqembu le-placebo. Ngakho-ke umbuzo uvela ukuthi i-biotin iyabangela yini ukuvuselela ngokuvuselela isimiso somzimba somzimba? Yingakho ucwaningo olwengeziwe luyadingeka.
Izwi elivela
Ucwaningo lunikeza Basikisela ukuthi i-biotin ingasisiza ngokuphepha nangokuphumelelayo ukuguqula ukuqhubekela phambili kokukhubazeka kubantu abane-MS eyinhloko noma eyesibili eqhubekayo. Noma kunjalo, ucwaningo olunzulu nolwengeziwe luzodingeka lwenziwe ngaphambi kokuba iziphi iziphetho zingadonselwa. Ngokwesibonelo, kungaba usizo ukubheka izilonda zobuchopho kwi-MRIs esikhathini esizayo.
Futhi, ucwaningo olusanda kuvela lubonisa ukuthi i-biotin ingase ingasebenzi kahle ekwelapheni ubuciko obubukwayo, okwenza ochwepheshe bahlaziye ikhanda kancane. Ngokubanzi, izifundo eziningi zidinga ukuphothulwa ukukhipha inzuzo yeqiniso ye-biotin ku-multiple sclerosis. Le nqubo eyinkimbinkimbi, kanti ngenkathi idla isikhathi, impela inesithakazelo sakho esithandayo.
> Imithombo:
> National MS Society. Imibuzo evame ukubuzwa mayelana ne-SPMS.
> Sedel F et al. Amanani aphezulu e-biotin ekuqhumeni okuqhubekayo okuqhubekayo kwesifo sokuphefumula: isifundo somqhubi. I-Mult Scler Relat Disord . 2015 uMar; 4 (2): 159-69.
> Tourbah A et al. MD1003 (i-high-dose biotin) ekwelapheni ukuqhuma okuqhubekayo okuqhubekayo: Ucwaningo olulawulwa ngokungahleliwe, oluphindwe kabili, oluyimpumputhe. I-Mult Scler. 2016 Nov; 22 (13): 1719-31.